ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1256

Mast Cells Contribute to the Development of Sialadenitis Associated with Sjögren’s Syndrome via Inducing Tissue Fibrosis by TGFβ Production

Shinjiro Kaieda1, Kyoko Fujimoto1 and Hiroaki Ida1, 1Kurume University School of Medicine, Kurume, Japan

Meeting: ACR Convergence 2020

Keywords: Collagen, Fibroblasts, Other, Sjögren's Syndrome

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 8, 2020

Title: Sjögren’s Syndrome Poster

Session Type: Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Mast cells have been implicated in many immune-inflammatory disorders. They mediate a variety of inflammatory and fibrotic conditions, but their role in sialadenitis in patients with primary Sjögren’s syndrome (pSS) is unclear. We examined whether mast cells play a critical role in the pathogenesis of pSS.

Methods: Labial salivary gland samples were collected from 22 individuals with pSS and 10 with sicca syndrome (controls). Saliva production was evaluated by Saxon’s test. Mast cell density in minor salivary glands was calculated at 400 magnification. The degree of fibrosis in minor labial salivary gland was graded on a quantitative scale as previously reported (Clin Exp Rheumatol.1998;16:63-65). We used immunohistochemistry to identify and quantify tryptase or TGFβ-positive mast cells and vimentin-positive fibroblasts. Fibrous tissue was identified by using EVG stain. Conditioned medium for fibroblast culture  was obtained from human mast cell line-1 (HMC-1 )cells stimulated with recombinant human IL-33 and SCF for 24 hours. Fibroblasts were treated with HMC-1 conditioned medium for 24 hours and type I collagen synthesis in fibroblast was evaluated by RT-qPCR. Neutralization antibodies for human TGFβ was utilized during fibroblast culture with HMC-1 conditioned medium or standard culture medium.

Results: We found that the number of mast cells in labial salivary glands of patients with pSS was significantly increased compared to that in control subjects (Figure 1 and Figure 2A). There was a significant negative correlation between the Saxon’s test results and the number of mast cells, suggesting the involvement of mast cells in the decreased salivary secretion (Figure 2B). There was no correlation between the intensity of lymphoid infiltration assessed by focus score and the mast cell density (Figure 2C). In contrast, a significant correlation between the number of mast cells and the degree of fibrosis was observed (Figure 2D).  Consistent with these findings, mast cells were proximal to EVG-stained fibrous tissue and vimentin-positive fibroblasts. We hypothesized that mast cells were involved in the development of tissue fibrosis via modulation of fibroblast immune function. Significant up-regulation of Col1a mRNA was observed in fibroblast with HMC-1 conditioned medium as inverse proportion to the degree of dilution compared to that of fibroblast with standard culture medium (Figure 3A). Furthermore, neutralization for TGFβ abolished upregulation of Col1a mRNA in fibroblast in HMC-1 conditioned medium, thus suggesting that HMC-1-derived TGFβ contributes to upregulation of type I collagen synthesis (Figure 3B). Immunohistochemistry revealed that tryptase-positive mast cells exhibited positive signal of TGFβ in serial section.

Conclusion: These results suggest a novel role for mast cells in the development of sialadenitis in patients with pSS by induction of tissue fibrosis via fibroblast collagen synthesis by TGFβ production.


Disclosure: S. Kaieda, None; K. Fujimoto, None; H. Ida, None.

To cite this abstract in AMA style:

Kaieda S, Fujimoto K, Ida H. Mast Cells Contribute to the Development of Sialadenitis Associated with Sjögren’s Syndrome via Inducing Tissue Fibrosis by TGFβ Production [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/mast-cells-contribute-to-the-development-of-sialadenitis-associated-with-sjogrens-syndrome-via-inducing-tissue-fibrosis-by-tgf%ce%b2-production/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/mast-cells-contribute-to-the-development-of-sialadenitis-associated-with-sjogrens-syndrome-via-inducing-tissue-fibrosis-by-tgf%ce%b2-production/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology